Michael S. Weiss
2019 - TG Therapeutics
In 2019, Michael S. Weiss earned a total compensation of $12.7M as Chief Executive Officer and President at TG Therapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $191,040 |
|---|---|
| Option Awards | $3,450,000 |
| Salary | $636,500 |
| Stock Awards | $8,397,186 |
| Total | $12,674,726 |
Weiss received $8.4M in stock awards, accounting for 66% of the total pay in 2019.
Weiss also received $191K in non-equity incentive plan, $3.5M in option awards and $636.5K in salary.
Rankings
In 2019, Michael S. Weiss' compensation ranked 475th out of 13,971 executives tracked by ExecPay. In other words, Weiss earned more than 96.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 475 out of 13,971 | 97th |
Division Manufacturing | 177 out of 5,695 | 97th |
Major group Chemicals And Allied Products | 45 out of 2,194 | 98th |
Industry group Drugs | 37 out of 1,880 | 98th |
Industry Pharmaceutical Preparations | 30 out of 1,392 | 98th |
Pay ratio
| Michael S. Weiss' Pay | $12,674,726 |
|---|---|
| Median Employee's Pay | $322,556 |
| Pay Ratio | 39to 1 |
In 2019, the annual total compensation of Michael S. Weiss was $12,674,726.
The annual total compensation of the median employee at TG Therapeutics was $322,556.
The ratio of Michael S. Weiss' pay to the pay of median employee was therefore 39 to one.
Source: SEC filing on April 29, 2020.
Weiss' colleagues
We found one more compensation record of an executive who worked with Michael S. Weiss at TG Therapeutics in 2019.
2019
Sean Power
TG Therapeutics